IFRX
InflaRx N.V.
NASDAQ · Healthcare · Biotechnology · DE
$2.22
−0.45%Institutional positioning
13F filings over the trailing two quarters
New 7Increased 7Reduced 11Sold out 35
| Filer | Action | Shares | Filed |
|---|---|---|---|
| SUVRETTA CAPITAL MANAGEMENT, LLC | Unchanged | 7,933,910 | May 15, 2026 |
| 683 CAPITAL MANAGEMENT, LLC | Unchanged | 3,315,000 | May 15, 2026 |
| BANK OF AMERICA CORP /DE/ | Reduced | 1,975,000 | May 18, 2026 |
| EVERSEPT PARTNERS, LP | Increased | 1,758,573 | May 15, 2026 |
| MORGAN STANLEY | Reduced | 1,175,576 | May 15, 2026 |
| MARSHALL WACE, LLP | Increased | 554,364 | May 15, 2026 |
| RAYMOND JAMES FINANCIAL INC | Increased | 395,803 | May 14, 2026 |
| SQUAREPOINT OPS LLC | Reduced | 301,987 | May 15, 2026 |
| T3 Companies, LLC | Unchanged | 291,014 | May 7, 2026 |
| CITADEL ADVISORS LLC | Increased | 202,990 | Sep 2, 2026 |
| TWO SIGMA INVESTMENTS, LP | Reduced | 189,075 | May 15, 2026 |
| DCF ADVISERS, LLC | Unchanged | 158,500 | May 11, 2026 |
| ADAR1 CAPITAL MANAGEMENT, LLC | New Position | 158,271 | May 18, 2026 |
| GSA CAPITAL PARTNERS LLP | New Position | 127,469 | May 8, 2026 |
| KESTRA ADVISORY SERVICES, LLC | Unchanged | 95,000 | Apr 30, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings